{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T00:32:23Z","timestamp":1722558743695},"posted":{"date-parts":[[2024,1,19]]},"group-title":"In Review","reference-count":36,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2024,1,19]],"date-time":"2024-01-19T00:00:00Z","timestamp":1705622400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2024,1,17]]},"abstract":"<title>Abstract<\/title>\n        <p><bold>Background<\/bold><italic>:<\/italic> Cryptococcosis is a life-threatening disease caused by <italic>Cryptococcus neoformans<\/italic> or <italic>C. gattii<\/italic>. Autoantibodies (auto-Abs) neutralizing granulocyte-macrophage colony-stimulating factor (GM-CSF) in otherwise healthy adults with cryptococcal meningitis have been described since 2013. We searched for neutralizing auto-Abs in sera from Colombian patients with non-HIV related cryptococcosis in a retrospective national cohort collected from 1997 to 2016. <bold>Methods:<\/bold> We reviewed clinical and laboratory records and assessed the presence of neutralizing auto-Abs in 30 HIV (-) adults presenting cryptococcosis (13 by <italic>C. gattii<\/italic>, and 17 by <italic>C. neoformans<\/italic>). \n<bold>Results:<\/bold> We detected auto-Abs neutralizing GM-CSF in the plasma of 9 out of 13 (69%) patients infected with <italic>C. gattii<\/italic> and 1 out of 17 (6%) patients with <italic>C. neoformans<\/italic>.  \n<bold>Conclusions:<\/bold> We report ten Colombian patients with cryptococcosis due to auto-Abs neutralizing GM-CSF. Nine of the ten patients were infected with <italic>C. gattii<\/italic>, and only one with <italic>C. neoformans.<\/italic><\/p>","DOI":"10.21203\/rs.3.rs-3873029\/v1","type":"posted-content","created":{"date-parts":[[2024,1,19]],"date-time":"2024-01-19T21:40:19Z","timestamp":1705700419000},"source":"Crossref","is-referenced-by-count":0,"title":["Autoantibodies neutralizing GM-CSF in HIV-negative Colombian patients infected with Cryptococcus gattii and C. neoformans"],"prefix":"10.21203","author":[{"given":"Carlos A.","family":"Arango-Franco","sequence":"first","affiliation":[{"name":"University of Antioquia (UdeA)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juli\u00e1n","family":"Rojas","sequence":"additional","affiliation":[{"name":"University of Antioquia (UdeA)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolina","family":"Firacative","sequence":"additional","affiliation":[{"name":"University del Rosario"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clara In\u00e9s","family":"Agudelo","sequence":"additional","affiliation":[{"name":"Instituto Nacional de Salud"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Luis","family":"Franco","sequence":"additional","affiliation":[{"name":"University of Antioquia (UdeA)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Laurent","family":"Casanova","sequence":"additional","affiliation":[{"name":"INSERM U1163, Necker Hospital for Sick Children"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Puel","sequence":"additional","affiliation":[{"name":"INSERM U1163, Necker Hospital for Sick Children"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jairo","family":"Lizarazo","sequence":"additional","affiliation":[{"name":"University of Pamplona"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Casta\u00f1eda","sequence":"additional","affiliation":[{"name":"Instituto Nacional de Salud"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9s A.","family":"Arias","sequence":"additional","affiliation":[{"name":"University of Antioquia (UdeA)"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"issue":"7","key":"ref1","doi-asserted-by":"crossref","first-page":"a019760","DOI":"10.1101\/cshperspect.a019760","article-title":"Cryptococcus neoformans and Cryptococcus gattii, the etiologic agents of cryptococcosis","volume":"4","author":"Kwon-Chung KJ","year":"2014","unstructured":"Kwon-Chung KJ, et al. Cryptococcus neoformans and Cryptococcus gattii, the etiologic agents of cryptococcosis. Cold Spring Harb Perspect Med. 2014;4(7):a019760.","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"2","key":"ref2","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3201\/eid1702.101020","article-title":"Risk factors for Cryptococcus gattii infection, British Columbia, Canada","volume":"17","author":"MacDougall L","year":"2011","unstructured":"MacDougall L, et al. Risk factors for Cryptococcus gattii infection, British Columbia, Canada. Emerg Infect Dis. 2011;17(2):193\u20139.","journal-title":"Emerg Infect Dis"},{"issue":"2","key":"ref3","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3390\/jof1020154","volume":"1","author":"Kwon-Chung KJ","year":"2015","unstructured":"Kwon-Chung KJ, Saijo T. Is J Fungi (Basel). 2015;1(2):154\u201367.","journal-title":"Is J Fungi (Basel)"},{"issue":"4","key":"ref4","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1128\/CMR.00126-13","article-title":"Cryptococcus gattii infections","volume":"27","author":"Chen SC","year":"2014","unstructured":"Chen SC, Meyer W, Sorrell TC. Cryptococcus gattii infections. Clin Microbiol Rev. 2014;27(4):980\u20131024.","journal-title":"Clin Microbiol Rev"},{"issue":"4","key":"ref5","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20211387","article-title":"Human autoantibodies underlying infectious diseases","volume":"219","author":"Puel A","year":"2022","unstructured":"Puel A et al. Human autoantibodies underlying infectious diseases. J Exp Med, 2022. 219(4).","journal-title":"J Exp Med"},{"issue":"6\u20137","key":"ref6","first-page":"783","article-title":"Autoantibodies against cytokines: phenocopies of primary immunodeficiencies?","volume":"139","author":"Ku CL","year":"2020","unstructured":"Ku CL, et al. Autoantibodies against cytokines: phenocopies of primary immunodeficiencies? Hum Genet. 2020;139(6\u20137):783\u201394.","journal-title":"Hum Genet"},{"issue":"3","key":"ref7","article-title":"Of Mycelium and Men: Inherent Human Susceptibility to Fungal Diseases","volume":"12","author":"Vinh DC","year":"2023","unstructured":"Vinh DC. Of Mycelium and Men: Inherent Human Susceptibility to Fungal Diseases. Pathogens, 2023. 12(3).","journal-title":"Pathogens"},{"issue":"8","key":"ref8","doi-asserted-by":"crossref","first-page":"3959","DOI":"10.4049\/jimmunol.1202526","article-title":"Anti-GM-CSF autoantibodies in patients with cryptococcal meningitis","volume":"190","author":"Rosen LB","year":"2013","unstructured":"Rosen LB, et al. Anti-GM-CSF autoantibodies in patients with cryptococcal meningitis. J Immunol. 2013;190(8):3959\u201366.","journal-title":"J Immunol"},{"issue":"1","key":"ref9","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1186\/s12931-022-02103-9","article-title":"Neutralizing GM-CSF autoantibodies in pulmonary alveolar proteinosis, cryptococcal meningitis and severe nocardiosis","volume":"23","author":"Salvator H","year":"2022","unstructured":"Salvator H, et al. Neutralizing GM-CSF autoantibodies in pulmonary alveolar proteinosis, cryptococcal meningitis and severe nocardiosis. Respir Res. 2022;23(1):280.","journal-title":"Respir Res"},{"issue":"5","key":"ref10","doi-asserted-by":"crossref","first-page":"ofac146","DOI":"10.1093\/ofid\/ofac146","article-title":"Opportunistic Infection Associated With Elevated GM-CSF Autoantibodies: A Case Series and Review of the Literature","volume":"9","author":"Lee E","year":"2022","unstructured":"Lee E, et al. Opportunistic Infection Associated With Elevated GM-CSF Autoantibodies: A Case Series and Review of the Literature. Open Forum Infect Dis. 2022;9(5):ofac146.","journal-title":"Open Forum Infect Dis"},{"issue":"1","key":"ref11","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41572-019-0066-3","article-title":"Pulmonary alveolar proteinosis","volume":"5","author":"Trapnell BC","year":"2019","unstructured":"Trapnell BC, et al. Pulmonary alveolar proteinosis. Nat Rev Dis Primers. 2019;5(1):16.","journal-title":"Nat Rev Dis Primers"},{"issue":"4","key":"ref12","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.4049\/jimmunol.1501512","article-title":"Local GM-CSF-Dependent Differentiation and Activation of Pulmonary Dendritic Cells and Macrophages Protect against Progressive Cryptococcal Lung Infection in Mice","volume":"196","author":"Chen GH","year":"2016","unstructured":"Chen GH, et al. Local GM-CSF-Dependent Differentiation and Activation of Pulmonary Dendritic Cells and Macrophages Protect against Progressive Cryptococcal Lung Infection in Mice. J Immunol. 2016;196(4):1810\u201321.","journal-title":"J Immunol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"836886","DOI":"10.3389\/fmed.2022.836886","article-title":"Central Nervous System Cryptococcosis in Patients With Sarcoidosis: Comparison With Non-sarcoidosis Patients and Review of Potential Pathophysiological Mechanisms","volume":"9","author":"Prevel R","year":"2022","unstructured":"Prevel R, et al. Central Nervous System Cryptococcosis in Patients With Sarcoidosis: Comparison With Non-sarcoidosis Patients and Review of Potential Pathophysiological Mechanisms. Front Med (Lausanne). 2022;9:836886.","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"ref14","article-title":"Cryptococcosis in Colombia: Compilation and Analysis of Data from Laboratory-Based Surveillance","volume":"4","author":"Escandon P","year":"2018","unstructured":"Escandon P et al. Cryptococcosis in Colombia: Compilation and Analysis of Data from Laboratory-Based Surveillance. J Fungi (Basel), 2018. 4(1).","journal-title":"J Fungi (Basel)"},{"issue":"11","key":"ref15","doi-asserted-by":"crossref","first-page":"e3272","DOI":"10.1371\/journal.pntd.0003272","article-title":"Retrospective study of the epidemiology and clinical manifestations of Cryptococcus gattii infections in Colombia from 1997\u20132011","volume":"8","author":"Lizarazo J","year":"2014","unstructured":"Lizarazo J, et al. Retrospective study of the epidemiology and clinical manifestations of Cryptococcus gattii infections in Colombia from 1997\u20132011. PLoS Negl Trop Dis. 2014;8(11):e3272.","journal-title":"PLoS Negl Trop Dis"},{"issue":"5","key":"ref16","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1007\/s10875-023-01451-5","article-title":"Anti-GM-CSF Neutralizing Autoantibodies in Colombian Patients with Disseminated Cryptococcosis","volume":"43","author":"Arango-Franco CA","year":"2023","unstructured":"Arango-Franco CA, et al. Anti-GM-CSF Neutralizing Autoantibodies in Colombian Patients with Disseminated Cryptococcosis. J Clin Immunol. 2023;43(5):921\u201332.","journal-title":"J Clin Immunol"},{"issue":"11","key":"ref17","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1093\/mmy\/myab041","article-title":"Antifungal susceptibility of clinical Cryptococcus gattii isolates from Colombia varies among molecular types","volume":"59","author":"Firacative C","year":"2021","unstructured":"Firacative C, Escand\u00f3n P. Antifungal susceptibility of clinical Cryptococcus gattii isolates from Colombia varies among molecular types. Med Mycol. 2021;59(11):1122\u20135.","journal-title":"Med Mycol"},{"issue":"9","key":"ref18","doi-asserted-by":"crossref","DOI":"10.1093\/mmy\/myac067","article-title":"Cryptococcus neoformans- and Cryptococcus gattii-specific IgG, IgA and IgM differ among children and adults with and without cryptococcosis from Colombia","volume":"60","author":"Becerra-\u00c1lvarez P","year":"2022","unstructured":"Becerra-\u00c1lvarez P et al. Cryptococcus neoformans- and Cryptococcus gattii-specific IgG, IgA and IgM differ among children and adults with and without cryptococcosis from Colombia. Med Mycol, 2022. 60(9).","journal-title":"Med Mycol"},{"issue":"12","key":"ref19","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1016\/S1473-3099(22)00499-6","article-title":"The global burden of HIV-associated cryptococcal infection in adults in 2020: a modelling analysis","volume":"22","author":"Rajasingham R","year":"2022","unstructured":"Rajasingham R, et al. The global burden of HIV-associated cryptococcal infection in adults in 2020: a modelling analysis. Lancet Infect Dis. 2022;22(12):1748\u201355.","journal-title":"Lancet Infect Dis"},{"issue":"7","key":"ref20","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1093\/cid\/ciad321","article-title":"Current Epidemiology and Clinical Features of Cryptococcus Infection in Patients Without Human Immunodeficiency Virus: A Multicenter Study in 46 Hospitals in Australia and New Zealand","volume":"77","author":"Coussement J","year":"2023","unstructured":"Coussement J, et al. Current Epidemiology and Clinical Features of Cryptococcus Infection in Patients Without Human Immunodeficiency Virus: A Multicenter Study in 46 Hospitals in Australia and New Zealand. Clin Infect Dis. 2023;77(7):976\u201386.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"ref21","doi-asserted-by":"crossref","first-page":"e60431","DOI":"10.1371\/journal.pone.0060431","article-title":"Predictors of mortality and differences in clinical features among patients with Cryptococcosis according to immune status","volume":"8","author":"Brizendine KD","year":"2013","unstructured":"Brizendine KD, Baddley JW, Pappas PG. Predictors of mortality and differences in clinical features among patients with Cryptococcosis according to immune status. PLoS ONE. 2013;8(3):e60431.","journal-title":"PLoS ONE"},{"issue":"8","key":"ref22","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.amjmed.2019.04.026","article-title":"Presentation and Mortality of Cryptococcal Infection Varies by Predisposing Illness: A Retrospective Cohort Study","volume":"132","author":"Hevey MA","year":"2019","unstructured":"Hevey MA, et al. Presentation and Mortality of Cryptococcal Infection Varies by Predisposing Illness: A Retrospective Cohort Study. Am J Med. 2019;132(8):977\u2013983e1.","journal-title":"Am J Med"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.fgb.2014.10.017","article-title":"Epidemiology of Cryptococcus and cryptococcosis in China","volume":"78","author":"Fang W","year":"2015","unstructured":"Fang W, Fa Z, Liao W. Epidemiology of Cryptococcus and cryptococcosis in China. Fungal Genet Biol. 2015;78:7\u201315.","journal-title":"Fungal Genet Biol"},{"year":"2018","author":"Azambuja AZ","key":"ref24","unstructured":"de Azambuja AZ et al. Cryptococcal Meningitis: A Retrospective Cohort of a Brazilian Reference Hospital in the Post-HAART Era of Universal Access. Can J Infect Dis Med Microbiol, 2018. 2018: p. 6512468."},{"issue":"4","key":"ref25","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1590\/0037-8682-0050-2018","article-title":"Cryptococcal meningitis epidemiology: 17 years of experience in a State of the Brazilian Pantanal","volume":"51","author":"Nunes JO","year":"2018","unstructured":"Nunes JO, et al. Cryptococcal meningitis epidemiology: 17 years of experience in a State of the Brazilian Pantanal. Rev Soc Bras Med Trop. 2018;51(4):485\u201392.","journal-title":"Rev Soc Bras Med Trop"},{"issue":"8","key":"ref26","doi-asserted-by":"crossref","first-page":"864","DOI":"10.3109\/13693786.2011.584198","article-title":"Characteristics and specificities of Cryptococcus infections in French Guiana, 1998\u20132008","volume":"49","author":"Debourgogne A","year":"2011","unstructured":"Debourgogne A, et al. Characteristics and specificities of Cryptococcus infections in French Guiana, 1998\u20132008. Med Mycol. 2011;49(8):864\u201371.","journal-title":"Med Mycol"},{"issue":"6515","key":"ref27","doi-asserted-by":"crossref","DOI":"10.1126\/science.abd4585","article-title":"Autoantibodies against type I IFNs in patients with life-threatening COVID-19","volume":"370","author":"Bastard P","year":"2020","unstructured":"Bastard P et al. Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Science, 2020. 370(6515).","journal-title":"Science"},{"issue":"4","key":"ref28","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20202486","article-title":"Auto-antibodies to type I IFNs can underlie adverse reactions to yellow fever live attenuated vaccine","volume":"218","author":"Bastard P","year":"2021","unstructured":"Bastard P et al. Auto-antibodies to type I IFNs can underlie adverse reactions to yellow fever live attenuated vaccine. J Exp Med, 2021. 218(4).","journal-title":"J Exp Med"},{"issue":"62","key":"ref29","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abl4348","article-title":"X-linked recessive TLR7 deficiency in ~\u20091% of men under 60 years old with life-threatening COVID-19","volume":"6","author":"Asano T","year":"2021","unstructured":"Asano T et al. X-linked recessive TLR7 deficiency in ~\u20091% of men under 60 years old with life-threatening COVID-19. Sci Immunol, 2021. 6(62).","journal-title":"Sci Immunol"},{"issue":"7988","key":"ref30","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/s41586-023-06717-x","article-title":"Autoantibodies against type I IFNs in humans with alternative NF-\u03baB pathway deficiency","volume":"623","author":"Voyer T","year":"2023","unstructured":"Le Voyer T, et al. Autoantibodies against type I IFNs in humans with alternative NF-\u03baB pathway deficiency. Nature. 2023;623(7988):803\u201313.","journal-title":"Nature"},{"issue":"1","key":"ref31","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1038\/s41467-019-10065-8","article-title":"Heterogeneous GM-CSF signaling in macrophages is associated with control of Mycobacterium tuberculosis","volume":"10","author":"Bryson BD","year":"2019","unstructured":"Bryson BD, et al. Heterogeneous GM-CSF signaling in macrophages is associated with control of Mycobacterium tuberculosis. Nat Commun. 2019;10(1):2329.","journal-title":"Nat Commun"},{"issue":"5","key":"ref32","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01514-17","article-title":"Role of Granulocyte-Macrophage Colony-Stimulating Factor Production by T Cells during","volume":"8","author":"Rothchild AC","year":"2017","unstructured":"Rothchild AC et al. Role of Granulocyte-Macrophage Colony-Stimulating Factor Production by T Cells during. mBio, 2017. 8(5).","journal-title":"mBio"},{"issue":"6","key":"ref33","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1189\/jlb.1204723","article-title":"Disruption of granulocyte macrophage-colony stimulating factor production in the lungs severely affects the ability of mice to control Mycobacterium tuberculosis infection","volume":"77","author":"Gonzalez-Juarrero M","year":"2005","unstructured":"Gonzalez-Juarrero M, et al. Disruption of granulocyte macrophage-colony stimulating factor production in the lungs severely affects the ability of mice to control Mycobacterium tuberculosis infection. J Leukoc Biol. 2005;77(6):914\u201322.","journal-title":"J Leukoc Biol"},{"issue":"2","key":"ref34","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1093\/cid\/ciab920","article-title":"Neutralizing Anti-Granulocyte-Macrophage Colony-Stimulating Factor Autoantibodies in Patients With Central Nervous System and Localized Cryptococcosis: Longitudinal Follow-up and Literature Review","volume":"75","author":"Kuo PH","year":"2022","unstructured":"Kuo PH, et al. Neutralizing Anti-Granulocyte-Macrophage Colony-Stimulating Factor Autoantibodies in Patients With Central Nervous System and Localized Cryptococcosis: Longitudinal Follow-up and Literature Review. Clin Infect Dis. 2022;75(2):278\u201387.","journal-title":"Clin Infect Dis"},{"issue":"8","key":"ref35","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1007\/s10875-022-01341-2","article-title":"Cryptococcus gattii Infection as the Major Clinical Manifestation in Patients with Autoantibodies Against Granulocyte-Macrophage Colony-Stimulating Factor","volume":"42","author":"Wang SY","year":"2022","unstructured":"Wang SY, et al. Cryptococcus gattii Infection as the Major Clinical Manifestation in Patients with Autoantibodies Against Granulocyte-Macrophage Colony-Stimulating Factor. J Clin Immunol. 2022;42(8):1730\u201341.","journal-title":"J Clin Immunol"},{"issue":"5","key":"ref36","doi-asserted-by":"crossref","first-page":"e0270821","DOI":"10.1128\/mBio.02708-21","article-title":"Cryptococcus gattii Species Complex as an Opportunistic Pathogen: Underlying Medical Conditions Associated with the Infection","volume":"12","author":"Yang DH","year":"2021","unstructured":"Yang DH, et al. Cryptococcus gattii Species Complex as an Opportunistic Pathogen: Underlying Medical Conditions Associated with the Infection. mBio. 2021;12(5):e0270821.","journal-title":"mBio"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-3873029\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-3873029\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T18:42:03Z","timestamp":1722537723000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-3873029\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,19]]},"references-count":36,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-3873029\/v1","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.1007\/s10875-024-01757-y","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2024,1,19]]},"subtype":"preprint"}}